350 related articles for article (PubMed ID: 34866541)
1. Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-middle-income countries.
Obeng-Kusi M; Habila MA; Roe DJ; Erstad B; Abraham I
J Med Econ; 2021 Nov; 24(sup1):1-13. PubMed ID: 34866541
[TBL] [Abstract][Full Text] [Related]
2. Comparative value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysis.
Obeng-Kusi M; Erstad B; Roe DJ; Abraham I
J Med Econ; 2022; 25(1):894-902. PubMed ID: 35748085
[TBL] [Abstract][Full Text] [Related]
3. The economic burden of Ebola virus disease: a review and recommendations for analysis.
Obeng-Kusi M; Martin J; Abraham I
J Med Econ; 2024; 27(1):309-323. PubMed ID: 38299454
[TBL] [Abstract][Full Text] [Related]
4. Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo.
Potluri R; Kumar A; Oriol-Mathieu V; Van Effelterre T; Metz L; Bhandari H
BMC Infect Dis; 2022 Oct; 22(1):769. PubMed ID: 36192683
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Ebola Virus Disease (EVD) preparedness and readiness program in Uganda: 2018 to 2019.
Nsubuga P; Masiira B; Kihembo C; Byakika-Tusiime J; Ryan C; Nanyunja M; Kamadjeu R; Talisuna A
Pan Afr Med J; 2021; 38():130. PubMed ID: 33912300
[TBL] [Abstract][Full Text] [Related]
6. Sustainable strategies for Ebola virus disease outbreak preparedness in Africa: a case study on lessons learnt in countries neighbouring the Democratic Republic of the Congo.
Ryan CS; Belizaire MD; Nanyunja M; Olu OO; Ahmed YA; Latt A; Kol MT; Bamuleke B; Tusiime J; Nsabimbona N; Conteh I; Nyashanu S; Ramadan PO; Woldetsadik SF; Nkata JM; Ntwari JT; Nzeyimana SD; Ouedraogo L; Batona G; Ndahindwa V; Mgamb EA; Armah M; Wamala JF; Guyo AG; Freeman AYS; Chimbaru A; Komakech I; Kuku M; Firmino WM; Saguti GE; Msemwa F; O-Tipo S; Kalubula PC; Nsenga N; Talisuna AO
Infect Dis Poverty; 2022 Dec; 11(1):118. PubMed ID: 36461100
[TBL] [Abstract][Full Text] [Related]
7. Impact of Ebola epidemics on the daily operation of existing systems in Eastern Democratic Republic of the Congo: a brief review.
Mukadi-Bamuleka D; Nkuba-Ndaye A; Mbala-Kingebeni P; Ahuka-Mundeke S; Muyembe-Tamfum JJ
J Med Econ; 2024; 27(1):184-192. PubMed ID: 38240249
[TBL] [Abstract][Full Text] [Related]
8. Lessons Learned from Reinforcing Epidemiologic Surveillance During the 2017 Ebola Outbreak in the Likati District, Democratic Republic of the Congo.
Hemingway-Foday JJ; Ngoyi BF; Tunda C; Stolka KB; Grimes KEL; Lubula L; Mossoko M; Kebela BI; Brown LM; MacDonald PDM
Health Secur; 2020 Jan; 18(S1):S81-S91. PubMed ID: 32004132
[TBL] [Abstract][Full Text] [Related]
9. The cost of public health interventions to respond to the 10th Ebola outbreak in the Democratic Republic of the Congo.
Zeng W; Samaha H; Yao M; Ahuka-Mundeke S; Wilkinson T; Jombart T; Baabo D; Lokonga JP; Yuma S; Mobula-Shufelt L
BMJ Glob Health; 2023 Oct; 8(10):. PubMed ID: 37848269
[TBL] [Abstract][Full Text] [Related]
10. 2020 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation.
Kinganda-Lusamaki E; Whitmer S; Lokilo-Lofiko E; Amuri-Aziza A; Muyembe-Mawete F; Makangara-Cigolo JC; Makaya G; Mbuyi F; Whitesell A; Kallay R; Choi M; Pratt C; Mukadi-Bamuleka D; Kavunga-Membo H; Matondo-Kuamfumu M; Mambu-Mbika F; Ekila-Ifinji R; Shoemaker T; Stewart M; Eng J; Rajan A; Soke GN; Fonjungo PN; Otshudiema JO; Folefack GLT; Pukuta-Simbu E; Talundzic E; Shedroff E; Bokete JL; Legand A; Formenty P; Mores CN; Porzucek AJ; Tritsch SR; Kombe J; Tshapenda G; Mulangu F; Ayouba A; Delaporte E; Peeters M; Wiley MR; Montgomery JM; Klena JD; Muyembe-Tamfum JJ; Ahuka-Mundeke S; Mbala-Kingebeni P
Lancet Microbe; 2024 Feb; 5(2):e109-e118. PubMed ID: 38278165
[TBL] [Abstract][Full Text] [Related]
11. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
12. Projections of epidemic transmission and estimation of vaccination impact during an ongoing Ebola virus disease outbreak in Northeastern Democratic Republic of Congo, as of Feb. 25, 2019.
Worden L; Wannier R; Hoff NA; Musene K; Selo B; Mossoko M; Okitolonda-Wemakoy E; Muyembe Tamfum JJ; Rutherford GW; Lietman TM; Rimoin AW; Porco TC; Kelly JD
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007512. PubMed ID: 31381606
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
Pearson CAB; Bozzani F; Procter SR; Davies NG; Huda M; Jensen HT; Keogh-Brown M; Khalid M; Sweeney S; Torres-Rueda S; ; ; Eggo RM; Vassall A; Jit M
PLoS Med; 2021 Oct; 18(10):e1003815. PubMed ID: 34606520
[TBL] [Abstract][Full Text] [Related]
14. What did we learn from preparing for cross-border transmission of Ebola virus disease into a complex humanitarian setting - The Republic of South Sudan?
Olu OO; Lako R; Wamala JF; Ramadan PO; Ryan C; Udenweze I; Berta K; Guyo AG; Sokemawu A; Tukuru M; Gray HJ; Chimbaru A
Infect Dis Poverty; 2020 Apr; 9(1):40. PubMed ID: 32312320
[TBL] [Abstract][Full Text] [Related]
15. Effect of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo.
Rupani N; Ngole ME; Lee JA; Aluisio AR; Gainey M; Perera SM; Ntamwinja LK; Matafali RM; Muhayangabo RF; Makoyi FN; Laghari R; Levine AC; Kearney AS
Emerg Infect Dis; 2022 Jun; 28(6):1180-1188. PubMed ID: 35608607
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the management of the tenth Ebola virus disease outbreak in the Democratic Republic of Congo: developing a multidisciplinary response model to strengthen the healthcare system during disease outbreaks.
Vivalya BM; Ayodeji OA; Bafwa YT; Muyisa LK; Piripiri AL; Mbeva JK
Global Health; 2021 Oct; 17(1):121. PubMed ID: 34663370
[TBL] [Abstract][Full Text] [Related]
17. The monetary value of human lives lost through Ebola virus disease in the Democratic Republic of Congo in 2019.
Kirigia JM; Muthuri RNDK; Muthuri NG
BMC Public Health; 2019 Sep; 19(1):1218. PubMed ID: 31481050
[TBL] [Abstract][Full Text] [Related]
18. Ebola Virus Disease Preparedness Assessment and Risk Mapping in Uganda, August-September 2018.
Nanziri C; Ario AR; Ntono V; Monje F; Aliddeki DM; Bainomugisha K; Kadobera D; Bulage L; Nsereko G; Kayiwa J; Nakiire L; Walwema R; Tusiime PK; Mabumba E; Makumbi I; Ocom F; Lamorde M; Kasule JN; Ward SE; Merrill RD
Health Secur; 2020; 18(2):105-113. PubMed ID: 32324074
[TBL] [Abstract][Full Text] [Related]
19. Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling.
Dawa J; Emukule GO; Barasa E; Widdowson MA; Anzala O; van Leeuwen E; Baguelin M; Chaves SS; Eggo RM
BMC Med; 2020 Aug; 18(1):223. PubMed ID: 32814581
[TBL] [Abstract][Full Text] [Related]
20. Ebola virus outbreak in North Kivu and Ituri provinces, Democratic Republic of Congo, and the potential for further transmission through commercial air travel.
Tuite AR; Watts AG; Khan K; Bogoch II
J Travel Med; 2019 Oct; 26(7):. PubMed ID: 31414699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
